Form 8-K - Current report:
SEC Accession No. 0001213900-23-005699
Filing Date
2023-01-27
Accepted
2023-01-27 17:00:21
Documents
13
Period of Report
2023-01-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea172309-8k_bluejay.htm   iXBRL 8-K 26286
2 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT, ENTERED INTO AND EFFECTIVE AS OF JANUAR ea172309ex10-1_bluejay.htm EX-10.1 11113
  Complete submission text file 0001213900-23-005699.txt   215903

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bjdx-20230127.xsd EX-101.SCH 3230
4 XBRL LABEL FILE bjdx-20230127_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bjdx-20230127_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT ea172309-8k_bluejay_htm.xml XML 3719
Mailing Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720
Business Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720 (978) 631-0152
Bluejay Diagnostics, Inc. (Filer) CIK: 0001704287 (see all company filings)

EIN.: 473552922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41031 | Film No.: 23564035
SIC: 3841 Surgical & Medical Instruments & Apparatus